Clinical trial
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in…
NCT00002658 · Medical Research Council, Other · Unknown status
Key facts
| NCT number | NCT00002658 |
|---|---|
| Title | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia |
| Official title | ACUTE MYELOID LEUKAEMIA TRIAL 12 |
| Lead sponsor | Medical Research Council, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Neutropenia |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, amsacrine, cyclophosphamide, cytarabine, daunorubicin hydrochloride, etoposide, idarubicin, mitoxantrone hydrochloride, thioguanine, tretinoin and 4 more |
| Enrollment | 2,000 |
| Start date | Jan 1, 1994 |
| First posted | Apr 10, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: